Авторы

  • Najmutdinova D.Q.
  • Ismoilova S.S.

Ключевые слова:

jigar fermentlari, metabolik stetatogepatoz, qandli diabet 2 tip.

Библиографические ссылки

Sun H, Saeedi P, Karuranga S, et al. IDF diabetes Atlas:global, regional and country-level diabetes prevalenceestimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2021; 183: 109119.

En Li Cho E, Ang CZ, Quek J, Fu CE, Lim LKE, Heng ZEQ, Tan DJH, Lim WH, Yong JN, Zeng R, Chee D, Nah B, Lesmana CRA, Bwa AH, Win KM, Faulkner C, Aboona MB, Lim MC, Syn N, Kulkarni AV, Suzuki H, Takahashi H, Tamaki N, Wijarnpreecha K, Huang DQ, Muthiah M, Ng CH, Loomba R. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut. 2023 Nov;72(11):2138-2148. doi: 10.1136/gutjnl-2023-330110. Epub 2023 Jul 25. PMID: 37491159.

Levinthal GN and Tavill AS. Liver disease and diabetes mellitus. Clin Diabetes. 1999;17(2):73-93.

Adibi A, Maleki S, Adibi P, Etminani R and Hovsepian S. Prevalence of nonalcoholic fatty liver disease and its related metabolic risk factors in Isfahan, Iran. Adv Biomed Res. 2017; 6:47. https://doi .org / 10.4103/2277-9175.204590

Younossi ZM, Ong JP, Takahashi H. Global nonalcoholic steatohepatitis council. A global survey of physician’s knowledge about nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2022;20: e1456-e1468.

Kanwal F, Shubrook JH, Younossi Z, Natarajan Y, Bugianesi E, Rinella ME, et al. Preparing for the NASH epidemic: A call to action. Diabetes Care. 2021;44(9):2162-2172.

Sunitha S, Gandham R, Wilma Delphine Silvia CR and Rao S. Evaluation of significance of liver enzymes as screening tests for the early detection of clinically asymptomatic non-alcoholic fatty liver disease in type 2 diabetes mellitus patients. Int J Biomed Adv Res. 2015;6(12):860-863. https://doi.org/10.74 39/ijbar

Sunitha S, Gandham R, Wilma Delphine Silvia CR and Rao S. Evaluation of significance of liver enzymes as screening tests for the early detection of clinically asymptomatic non-alcoholic fatty liver disease in type 2 diabetes mellitus patients. Int J Biomed Adv Res. 2015;6(12):860-863. https://doi.org/10.74 39/ijbar

Philip R, Mathias M, Kumari SN, Gowda DK and Shetty JK. Evalation of relationship between markers of liver function and the onset of type 2 diabetes. Nitte Univ J Health Sci. 2014;4(2):90.

Idris AS, Mekky KF, Abdalla BE and Ali KA. Liver function tests in type 2 Sudanese diabetic patients. Int J Nutr Metab. 2011;3(2):17-21.

Shibabaw T, Dessie G, Molla MD, Zerihun MF and Ayelign B. Assessment of liver marker enzymes and its association with type 2 diabetes mellitus in Northwest Ethiopia. BMC Res Notes. 2019;12(1):707.

Islam S, Rahman S, Haque T, Sumon AH, Ahmed AM and Ali N. Prevalence of elevated liver enzymes and its association with type 2 diabetes: A cross-sectional study in Bangladeshi adults. Endocrinol Diabetes Metab. 2020;3(2):e00116.